NEW YORK and MOUNTAIN VIEW, Calif., Oct. 30, 2019 /PRNewswire/ — AliveCor, the leader in AI based, personal ECG technology, and provider of enterprise cardiology solutions; and Huami Corporation (NYSE:HMI), a global leader in biometric, data-driven wearables, today announced a multi-faceted global strategic alliance that combines the technologies of each company to deliver a […]
Other News
Zynex Announces 2019 Third Quarter Financial Results
– Revenue increased 45% year over year to $11.8 million – Orders increased 95% year over year – Net income $2.0 million; Diluted EPS $0.06 – Adjusted EBITDA $2.8M – Thirteenth consecutive quarter of positive net income ENGLEWOOD, Colo., Oct. 29, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing […]
Orsiro Coronary Drug-Eluting Stent Receives Market Approval in China
BIOTRONIK’s Ultrathin-Strut Drug-Eluting Stent Soon Available in China Following Market Approval BEIJING, China and BUELACH, Switzerland, October 30, 2019 – BIOTRONIK announced today that its Orsiro® coronary drug-eluting stent (DES) has been approved for sale in China by the National Medical Products Administration. The company expects to make the device available to Chinese patients […]
New Intermountain Study Aims to Determine the Most Effective Method to Identify People at Risk for Heart Disease Before They Ever Develop Problems
SALT LAKE CITY–(BUSINESS WIRE)–Researchers from the Intermountain Healthcare Heart Institute are launching one of the largest and most ambitious research initiatives ever undertaken in the state of Utah to test a new standard of care to better identify and treat people at risk of having a heart attack – and […]
The Surmodics Sundance™ Sirolimus-Coated Balloon Catheter Earns FDA Breakthrough Device Status
Sundance™ Sirolimus-Coated Balloon will receive prioritization throughout the FDA submission and review process to provide patients and physicians timely access to medical devices EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United […]
BioSig Appoints Andrew Ballou as Vice President of Investor Relations
Westport, CT, Oct. 29, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company appointed Mr. […]
CardioFocus® Treats First Patients With HeartLight® Endoscopic Ablation System In France
MARLBOROUGH, Mass., Oct. 29, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight Endoscopic Ablation System as part of an exclusive distribution partnership with MicroPort® CRM France. To […]
HeartVista Receives FDA 510(k) Clearance for One Click™ Cardiac MRI Package, the First AI-assisted Cardiac MRI Scan Solution
LOS ALTOS, Calif.–(BUSINESS WIRE)–HeartVista, a pioneer in AI-assisted MRI solutions, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration to deliver its AI-assisted One Click™ MRI acquisition software for cardiac exams. Despite the many advantages of cardiac MRI, or cardiac magnetic resonance (CMR), its use […]
Journal of Endovascular Therapy Publishes Peer Reviewed Article Highlighting Real-World Use of the Tack Endovascular System®
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the peer- reviewed publication, “Practical Applications of Tack Implants for Infrainguinal Dissection Repair: A Single-Center Experience” currently available online, with the article scheduled to be published in the February 2020 issue of Journal of […]
Endologix, Inc. Comments on Recent FDA Update on Type III Endoleaks with AFX® Endovascular AAA System
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced a response to the U.S. Food and Drug Administration (FDA) update regarding Type III endoleaks with the AFX Endovascular AAA System. Dr. Matt Thompson, Chief Medical Officer of Endologix Inc. commented, “On […]



